BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23086420)

  • 1. Myotubularin phosphoinositide phosphatases in human diseases.
    Amoasii L; Hnia K; Laporte J
    Curr Top Microbiol Immunol; 2012; 362():209-33. PubMed ID: 23086420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WANTED - Dead or alive: Myotubularins, a large disease-associated protein family.
    Raess MA; Friant S; Cowling BS; Laporte J
    Adv Biol Regul; 2017 Jan; 63():49-58. PubMed ID: 27666502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.
    Laporte J; Bedez F; Bolino A; Mandel JL
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R285-92. PubMed ID: 12925573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.
    Kim SA; Taylor GS; Torgersen KM; Dixon JE
    J Biol Chem; 2002 Feb; 277(6):4526-31. PubMed ID: 11733541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of myotubularin phosphatases activity on phosphoinositides in vitro and ex vivo.
    Rohde HM; Tronchère H; Payrastre B; Laporte J
    Methods Mol Biol; 2009; 462():265-78. PubMed ID: 19160676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of myotubularins in blood platelets: Characterization and potential diagnostic of X-linked myotubular myopathy.
    Mansour R; Severin S; Xuereb JM; Gratacap MP; Laporte J; Buj-Bello A; Tronchère H; Payrastre B
    Biochem Biophys Res Commun; 2016 Jul; 476(3):167-73. PubMed ID: 27155155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotubularin phosphatases: policing 3-phosphoinositides.
    Robinson FL; Dixon JE
    Trends Cell Biol; 2006 Aug; 16(8):403-12. PubMed ID: 16828287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth type 4B demyelinating neuropathy: deciphering the role of MTMR phosphatases.
    Previtali SC; Quattrini A; Bolino A
    Expert Rev Mol Med; 2007 Sep; 9(25):1-16. PubMed ID: 17880751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases.
    Schaletzky J; Dove SK; Short B; Lorenzo O; Clague MJ; Barr FA
    Curr Biol; 2003 Mar; 13(6):504-9. PubMed ID: 12646134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endosomal phosphoinositides and human diseases.
    Nicot AS; Laporte J
    Traffic; 2008 Aug; 9(8):1240-9. PubMed ID: 18429927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between myotubularins and Ca
    Dai N; Groenendyk J; Michalak M
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119739. PubMed ID: 38710289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure and regulation of myotubularin phosphatases.
    Begley MJ; Dixon JE
    Curr Opin Struct Biol; 2005 Dec; 15(6):614-20. PubMed ID: 16289848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myotubularin family: from genetic disease to phosphoinositide metabolism.
    Laporte J; Blondeau F; Buj-Bello A; Mandel JL
    Trends Genet; 2001 Apr; 17(4):221-8. PubMed ID: 11275328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy.
    Tosch V; Rohde HM; Tronchère H; Zanoteli E; Monroy N; Kretz C; Dondaine N; Payrastre B; Mandel JL; Laporte J
    Hum Mol Genet; 2006 Nov; 15(21):3098-106. PubMed ID: 17008356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome.
    Begley MJ; Taylor GS; Kim SA; Veine DM; Dixon JE; Stuckey JA
    Mol Cell; 2003 Dec; 12(6):1391-402. PubMed ID: 14690594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.
    Amoasii L; Bertazzi DL; Tronchère H; Hnia K; Chicanne G; Rinaldi B; Cowling BS; Ferry A; Klaholz B; Payrastre B; Laporte J; Friant S
    PLoS Genet; 2012; 8(10):e1002965. PubMed ID: 23071445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice.
    Robinson FL; Niesman IR; Beiswenger KK; Dixon JE
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4916-21. PubMed ID: 18349142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease.
    Robinson FL; Dixon JE
    J Biol Chem; 2005 Sep; 280(36):31699-707. PubMed ID: 15998640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of phosphoinositide phosphatases in genetic diseases: the case of myotubularin.
    Tronchère H; Buj-Bello A; Mandel JL; Payrastre B
    Cell Mol Life Sci; 2003 Oct; 60(10):2084-99. PubMed ID: 14618257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1.
    Srivastava S; Li Z; Lin L; Liu G; Ko K; Coetzee WA; Skolnik EY
    Mol Cell Biol; 2005 May; 25(9):3630-8. PubMed ID: 15831468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.